Key facts
- This page summarizes Sally E. Blount's Form 4 filing for ABBOTT LABORATORIES (ABT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 May 2025, 17:04.
Sally E. Blount - 30 Apr 2025 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)
- Reporting relationship
- Director
- Issuer ticker
- ABT
- Reported as of
- 30 Apr 2025
- Net transaction value
- -$337,116
- SEC form
- 4
- Accepted by SEC
- 02 May 2025, 17:04:05 UTC
- Prior SEC filing
- 29 Apr 2025
- Next SEC filing
- 28 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sally E. Blount by Jessica H. Paik, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sally E. Blount filed Form 4 for ABBOTT LABORATORIES (ABT) on 02 May 2025.
Change
- Previous filing in this sequence was filed on 29 Apr 2025.
- Current net transaction value: -$337,116.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001537286
Primary reporting owner
Blount Sally E.
- Relationship
- Director
- Address
- 100 ABBOTT PARK ROAD, ABBOTT PARK
- Signature
- /s/ Sally E. Blount by Jessica H. Paik, Attorney-in-Fact
- Signature date
- 02 May 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ABT
transaction
Common shares without par value
Sale
- Transaction value
- $337,116
- Shares
- -2,600
- Change %
- -7.1%
- Price
- $129.66
- Shares after
- 34,058
- Date
- 30 Apr 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.